Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of SPM-011 (Borofalan-10B) with BNCT System in recurrent malignant glioma
jRCT2080224670Phase 2Completed
- Sponsor
- Stella Pharma
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of boronophenylalanine in malignant glioma, sponsored by Stella Pharma. Primary endpoints: 1-year survival rate and overall survival. Started May 2019; status: completed.
02
Drugs
boronophenylalanine
03
Conditions
malignant glioma
Beyond the preview
Go deeper on jRCT2080224670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224670.